Meeting
2013 ASCO Quality Care Symposium
Trends in chemotherapy-related treatment of advanced-stage colorectal (CRC) cancer.
Authors
Cathy Bradley
Virginia Commonwealth University, Richmond, VA
Cathy Bradley, K. Robin Yabroff, Joan L. Warren, Neetu Chawla, Christopher Zeruto, Elizabeth B. Lamont
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Practice of Quality and Health Reform
Track
Practice of Quality,Health Reform: Implications for Costs and Quality
Sub Track
Measuring Value and Costs
Citation
J Clin Oncol 31, 2013 (suppl 31; abstr 258)
Abstract #
258
Poster Bd #
F15
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Trends in chemotherapy-related treatment of late-stage colon and rectal cancer.
First Author: Cathy Bradley
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Anlotinib combined with mXELIRI as second-line treatment in advanced colorectal cancer pretreated with bevacizumab plus standard chemotherapy: A single-arm, phase IB/II study.
First Author: Xin Qu
Poster
2019 Gastrointestinal Cancers Symposium
CD276-positive circulating endothelial cells in advanced colorectal cancer.
First Author: Elske C. Gootjes
Poster
2018 ASCO Annual Meeting
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without systemic bevacizumab, for patients with advanced cancer and liver involvement.
First Author: Elena Fountzilas